title: Augmentation of antitumor effect of recombinant interleukin-2 activated killer cells by the administration of rIL-2 and lentinan.
authors.affiliation: Department of Obstetrics and Gynecology, Osaka University Medical School.
authors.forename: H
authors.initials: H
authors.lastname: Shimizu
authors.forename: M
authors.initials: M
authors.lastname: Inoue
authors.forename: C
authors.initials: C
authors.lastname: Shimizu
authors.forename: J
authors.initials: J
authors.lastname: Saito
authors.forename: G
authors.initials: G
authors.lastname: Ueda
authors.forename: O
authors.initials: O
authors.lastname: Tanizawa
mesh_terms: D000818:Animals; D005260:Female; D006801:Humans; D007116:Immunization, Passive; D007376:Interleukin-2 / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007912:Lentinan / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009368:Neoplasm Transplantation; D011134:Polysaccharides / Q000494:pharmacology*; D011994:Recombinant Proteins; D014183:Transplantation, Heterologous; D014594:Uterine Neoplasms / Q000276:immunology / Q000628:therapy*
chemical_list: D007376:Interleukin-2; D011134:Polysaccharides; D011994:Recombinant Proteins; D007912:Lentinan